[go: up one dir, main page]

CY1117596T1 - Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης - Google Patents

Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης

Info

Publication number
CY1117596T1
CY1117596T1 CY20161100345T CY161100345T CY1117596T1 CY 1117596 T1 CY1117596 T1 CY 1117596T1 CY 20161100345 T CY20161100345 T CY 20161100345T CY 161100345 T CY161100345 T CY 161100345T CY 1117596 T1 CY1117596 T1 CY 1117596T1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical
formoterol
compositions
dipropional
airport
Prior art date
Application number
CY20161100345T
Other languages
English (en)
Inventor
Gaetano Brambilla
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42035850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1117596(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP14155333.9A external-priority patent/EP2775197B1/fr
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of CY1117596T1 publication Critical patent/CY1117596T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά φαρμακευτικές συνθέσεις για χρήση στη χορήγηση φαρμάκων δια εισπνοής. Συγκεκριμένα, η παρούσα εφεύρεση αφορά μία φαρμακευτική σύνθεση η οποία περιλαμβάνει διπροπιονική βεκλομεθαζόνη και ένα άλας φορμοτερόλης για χρήση σε υπό πίεση ευρισκόμενους εισπνευστήρες δοσιμετρημένης δόσης (MDI's).
CY20161100345T 2009-10-02 2016-04-26 Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης CY1117596T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172083 2009-10-02
EP14155333.9A EP2775197B1 (fr) 2013-03-04 2014-02-17 Dispositif d'éclairage et/ou de signalisation pour véhicule automobile, comportant un guide de lumière

Publications (1)

Publication Number Publication Date
CY1117596T1 true CY1117596T1 (el) 2017-04-26

Family

ID=42035850

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20141100517T CY1115266T1 (el) 2009-10-02 2014-07-10 Φαρμακευτικες συνθεσεις αερολυματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης
CY20161100345T CY1117596T1 (el) 2009-10-02 2016-04-26 Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20141100517T CY1115266T1 (el) 2009-10-02 2014-07-10 Φαρμακευτικες συνθεσεις αερολυματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης

Country Status (21)

Country Link
US (1) US8420060B2 (el)
EP (2) EP2482799B1 (el)
KR (1) KR101778814B1 (el)
CN (2) CN102548537B (el)
AR (2) AR078494A1 (el)
BR (1) BR112012007484A2 (el)
CA (1) CA2776266C (el)
CY (2) CY1115266T1 (el)
DK (2) DK2727582T3 (el)
ES (2) ES2487626T3 (el)
HR (2) HRP20140818T1 (el)
HU (1) HUE029159T2 (el)
JO (1) JO3024B1 (el)
ME (1) ME02398B (el)
PL (2) PL2727582T3 (el)
PT (1) PT2482799E (el)
RS (2) RS54721B1 (el)
RU (1) RU2650175C2 (el)
SI (2) SI2727582T1 (el)
TW (1) TWI449523B (el)
WO (1) WO2011038872A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119777B2 (en) * 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
HUE069624T2 (hu) * 2012-01-25 2025-03-28 Chiesi Farm Spa Kortikoszteroidot és béta-adrenerg szert tartalmazó száraz porkészítmény inhalálással történõ beadásra
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
EP3383366B2 (en) 2015-12-04 2024-06-05 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
CN112438966B (zh) * 2019-08-30 2022-08-26 四川普锐特药业有限公司 一种医用定量吸入气雾剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
DE69412626T2 (de) 1993-07-15 1999-01-28 Minnesota Mining and Mfg. Co., St. Paul, Minn. Dichtungen für eine vorrichtung zum abgeben eines aerosols
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
IT1317720B1 (it) 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
UA73986C2 (uk) 2000-05-22 2005-10-17 К'Єзі Фармачеутічі С.П.А. АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ
US6472563B1 (en) * 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1982709A1 (en) * 2007-04-19 2008-10-22 CHIESI FARMACEUTICI S.p.A. Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma
RU2356537C2 (ru) * 2007-07-25 2009-05-27 Закрытое Акционерное Общество (ЗАО) "Пульмомед" Фармацевтический состав дозированных аэрозолей, содержащий противоастматические лекарственные средства в виде суспензий, растворов, эмульсий, растворов и эмульсий

Also Published As

Publication number Publication date
CN103919785B (zh) 2016-08-24
EP2482799B1 (en) 2014-06-18
JO3024B1 (ar) 2016-09-05
SI2482799T1 (sl) 2014-10-30
RS53514B1 (sr) 2015-02-27
TW201119644A (en) 2011-06-16
AR078494A1 (es) 2011-11-09
WO2011038872A1 (en) 2011-04-07
PL2482799T3 (pl) 2014-11-28
BR112012007484A2 (pt) 2020-06-09
HRP20140818T1 (hr) 2014-10-10
RU2012112454A (ru) 2013-11-10
DK2727582T3 (en) 2016-05-17
CY1115266T1 (el) 2017-01-04
KR101778814B1 (ko) 2017-09-15
HUE029159T2 (hu) 2017-02-28
EP2727582A1 (en) 2014-05-07
PL2727582T3 (pl) 2016-06-30
HK1167817A1 (en) 2012-12-14
HRP20160630T1 (hr) 2016-07-01
EP2482799A1 (en) 2012-08-08
SI2727582T1 (sl) 2016-05-31
CN102548537B (zh) 2014-06-25
RU2650175C2 (ru) 2018-04-10
TWI449523B (zh) 2014-08-21
CA2776266C (en) 2017-11-28
CN103919785A (zh) 2014-07-16
US8420060B2 (en) 2013-04-16
ES2487626T3 (es) 2014-08-22
EP2727582B1 (en) 2016-03-16
KR20120100901A (ko) 2012-09-12
US20110081301A1 (en) 2011-04-07
ES2568913T3 (es) 2016-05-05
CN102548537A (zh) 2012-07-04
HK1199214A1 (en) 2015-06-26
PT2482799E (pt) 2014-08-06
AR123674A2 (es) 2023-01-04
DK2482799T3 (da) 2014-09-01
CA2776266A1 (en) 2011-04-07
RS54721B1 (sr) 2016-08-31
ME02398B (me) 2016-09-20

Similar Documents

Publication Publication Date Title
AR079726A1 (es) Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc) . composicion farmaceutica.frasco de aerosol. metodo.conjunto de componentes
IL216467B (en) Pharmaceutical compositions deliverable from a metered dose inhaler comprising glycopyrrolate or formoterol and their use in treatment of pulmonary diseases
CY1125382T1 (el) Συνθεση για εισπνοη που περιεχει ακλιδινιο για τη θεραπευτικη αντιμετωπιση του ασθματος
WO2007121913A3 (en) Pharmaceutical solution formulations for pressurised metered dose inhalers
CY1117596T1 (el) Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης
BR112014029735A2 (pt) forma de dosagem e formulação de abediterol
BR112014008609A2 (pt) composição farmacêutica, recipiente vedado, inalador de dosagem medida, método para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica
BR112013029202A2 (pt) solução farmacêutica, recipiente selado, inalador de dose medida, método para tratar um paciente que sofre ou que está susceptível a sofrer de um distúrbio respiratório, usos de um propelente, de uma composição farmacêutica, e, de um aparelho de administração de medicamentos que contém uma composição farmacêutica
TR201109804A2 (tr) Tek dozlu inhalasyon cihazı.
WO2012040228A3 (en) Aerosol composition for administering drugs
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
MD20140131A2 (ro) Doză şi formă preparativă nouă pentru inhalare care cuprinde aclidiniu
TR200907917A2 (tr) Kuru toz inhaleri.
BR112015027247A2 (pt) composições farmacêuticas inaláveis e dispositivos inaladores contendo as mesmas
EA201591415A1 (ru) Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
CO6270213A2 (es) Composiciones farmaceuticas que comprenden acido montelukast y un unhibidor depde-4 o un corticoesteroide inhalado para administracion por inhalacion
MX2014001940A (es) Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.
CR10261A (es) Formulaciones novedosas
TR200907238A2 (tr) Tiotropyum içeren kombinasyonun blisterde taşınması.
TR200907914A2 (tr) Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
BR112014003907A2 (pt) método para preparar inalador pulverizado de dose medida para tratar doença respiratória
ECSP088768A (es) Envase para inhaladores de dosis múltiples con propiedades optimizadas de vaciado
BR102012008322B8 (pt) formulações medicinais em aerossol que não debilitam a camada de ozônio e com baixo efeito estufa